Mycophenolate is an immunosuppressive agent used to prevent your body from rejecting a kidney, liver, or heart transplant. Mycophenolate is usually given with cyclosporine (Sandimmune, Neoral) and a steroid medication. Learn about side effects, dosages,
The initial oral dose of CELLCEPT should be given as soon as possible following kidney, heart or liver transplant. It is recommended that CELLCEPT be administered on an empty stomach. In stable transplant patients, however, CELLCEPT may be administered with food if necessary [seeCLINICAL PHARMACOLOG...
Mycophenolate mofetil reduces calcineurin inhibitor-induced side effects after liver transplantation 来自 Semantic Scholar 喜欢 0 阅读量: 19 作者:R Pfitzmann,J Klupp,JM Langrehr,R Neuhaus,P Neuhaus 摘要: Author information: (1)Department of Surgery, Charité, Virchow-Klinikum, Humboldt-University ...
SRL in combination with MMF provided sufficient immunosuppression of liver allografts in the late course after LTX. Side effects were reversible with dose reduction or cessation of therapy. We can thus conclude that SRL might offer an immunosuppressive therapy for patients with renal or neurological ...
”for information about other serious side effects. What are mycophenolate mofetil tablets? • Mycophenolate mofetil tablets are a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver transplant. Rejection is when the body’s ...
Serious side effects were uncommon as only one patient required discontinuation of the medication. However, longer follow-up and larger study populations are needed in the future to better determine its efficacy and safety. 展开 关键词: Calcineurin-inhibitors mycophenolate mofetil nephrotoxicity liver ...
for information about other serious side effects. What are mycophenolate mofetil capsules? • Mycophenolate mofetil capsules are a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver transplant. Rejection is when the body’s ...
To assess separately usefulness for achieving current (or improved) targets in anti-rejection therapy and reducing calcineurin inhibitor side-effects of mycophenolate mofetil and enteric-coated mycophenolate sodium as immunosuppressive agents for liver-transplanted patients....
The initial oral dose of MYHIBBIN should be given as soon as possible following kidney, heart or liver transplant. It is recommended that MYHIBBIN be administered on an empty stomach. In stable transplant patients, however, MYHIBBIN may be administered with food if necessary [seeCLINICAL PHARM...
Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver of unknowncause. Typically, immune suppressive therapy is used initially for treatment, either in the form of steroids or Azathioprime. In a small proportion of patients, steroids resistance or steroid intolerance develops. Wh...